IOC while CLSA retained buy calls on SBI Life and Dalmia Bharat. Macquarie retained an outperform rating on HDFC Bank.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
Macquarie maintained an outperform rating on HDFC Bank with a target price of Rs 2075. The private sector bank is on the right track for consolidation.
It is bringing down loan growth and is focused more on the net interest margins (NIMs). “In our view, HDFC Bank needs to grow its deposits 400bps higher than loans over the next three years to get back to the pre-merger NIMs,” said the note.
“4-5% downside to our numbers if assumed 13% loan growth for the next couple of years and deposit growth of 17-18%,” the note added.
The global investment bank is of the view that it will take another couple of quarters before one can see NIM improvement and core PPOP growth.
CLSA maintained a buy rating on SBI Life but raised the target price to Rs 1730 from Rs 1620 earlier.
The commission was up 25% on a YoY basis versus 74%-94% for the peer group. There is a limited impact of surrender value regulations as per management.
The competition is set to rise but SBI's wide presence gives it an advantage. APE growth and margin outlook are the best in the industry.
CLSA upgraded Dalmia Bharat to buy from outperform earlier and has also raised the target price to Rs 2700 from Rs 2680 earlier.
The Q3 Ebitda was largely in line with estimates and the profitability is also in line. The stock is upgraded to a buy post-under-performance.